Clarion New Enterprise Commercialization Survey Highlights
The first Clarion New Enterprise Commercialization (NEC) survey was completed by 19 senior executives representing 14 emerging biopharma companies across a broad range of functions and therapeutic areas. Here is a summary of the survey findings:
Clarion is a life sciences strategy and organizational consultancy that works together with its clients to envision, craft, and enable growth through innovation and leadership. Across therapeutic categories, Clarion collaborates deeply with its clients to tackle their most complex cross-functional business challenges and decisions throughout the product and company lifecycle. With over 15 years of unparalleled experience in new product commercialization, Clarion partners with leaders in the biopharma industry to guide strategic decision-making necessary to launch a first asset or expand an existing portfolio.